Pivotal Trial of the Boomerang Catheter for pDVA

NAEnrolling by invitationINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

April 16, 2024

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2029

Conditions
Chronic Limb-Threatening Ischemia
Interventions
DEVICE

Boomerang Catheter

The study device used for this procedure makes an anastomosis between a tibial vein and a tibial artery to direct blood flow around blocked arteries.

Trial Locations (16)

10065

Weill Cornell Medical Center, New York

19104

Penn Medicine, Philadelphia

19805

EndoVascular Consultants, Wilmington

28906

Sunrise Vascular, Murphy

32080

Advanced Endovascular Institute, Saint Augustine

32256

First Coast Cardiovascular Institute, Jacksonville

60612

Rush University Medical Center, Chicago

70360

Cardiovascular Institute of the South, Houma

75235

UT Southwestern Medical Center, Dallas

77054

HOPE Vascular and Podiatry, Houston

80023

Advanced Heart and Vein Center, Thorton

90602

PIH Whittier Hospital, Whittier

97223

Advanced Vascular Centers, Tigard

98133

University of Washington Medicine, Seattle

08205

Vascular Institute at AMI, Galloway

07052

American Endovascular and Amputation Prevention, West Orange

Sponsors
All Listed Sponsors
lead

Aveera Medical, Inc.

INDUSTRY

NCT06311773 - Pivotal Trial of the Boomerang Catheter for pDVA | Biotech Hunter | Biotech Hunter